Dilemma of treating schizophrenia during pregnancy: a Case series and a review of literature

[1] Abel KM(2013)Fetal antipsychotic exposure in a changing landscape: seeing the future Br J Psychiatry 202 321-323

[2] Freeman MP(2013)Pregnancy and psychiatric disorders: inherent risks and treatment decisions J Clin Psychiatry. 74 373-374

[3] Brunner E(2013)Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance BMC Pharmacol Toxicol 14 38-288

[4] Falk DM(2008)Maternal use of antipsychotics in early pregnancy and delivery outcome J Clin Psychopharmacol 28 279-60

[5] Jones M(2010)Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Res 116 55-44

[6] Dey DK(2005)The potential risks of commonly prescribed antipsychotics: during pregnancy and lactation Psychiatry (Edgmont) 2 36-904

[7] Shatapathy CC(2014)Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report Ther Clin Risk Manag 10 901-346

[8] Reis M(2006)Meningocele and ankyloblepharon following in utero exposure to olanzapine Eur Psychiatry 21 345-222

[9] Källén B(2006)Hip dysplasia following a case of olanzapine exposed pregnancy: a questionable association Arch Womens Ment Health 9 219-90

[10] Lin HC(2008)The clinical dilemma–prescribing in pregnancy Psychiatr Danub 20 88-1760

[1] Abel KM(2013)Fetal antipsychotic exposure in a changing landscape: seeing the future Br J Psychiatry 202 321-323

[2] Freeman MP(2013)Pregnancy and psychiatric disorders: inherent risks and treatment decisions J Clin Psychiatry. 74 373-374

[3] Brunner E(2013)Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance BMC Pharmacol Toxicol 14 38-288

[4] Falk DM(2008)Maternal use of antipsychotics in early pregnancy and delivery outcome J Clin Psychopharmacol 28 279-60

[5] Jones M(2010)Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Res 116 55-44

[6] Dey DK(2005)The potential risks of commonly prescribed antipsychotics: during pregnancy and lactation Psychiatry (Edgmont) 2 36-904

[7] Shatapathy CC(2014)Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report Ther Clin Risk Manag 10 901-346

[8] Reis M(2006)Meningocele and ankyloblepharon following in utero exposure to olanzapine Eur Psychiatry 21 345-222

[9] Källén B(2006)Hip dysplasia following a case of olanzapine exposed pregnancy: a questionable association Arch Womens Ment Health 9 219-90

[10] Lin HC(2008)The clinical dilemma–prescribing in pregnancy Psychiatr Danub 20 88-1760